Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
New closed-loop insulin systems
by
Hovorka, Roman
, Boughton, Charlotte K
in
Closed loop systems
/ Diabetes
/ Diabetes mellitus (insulin dependent)
/ Insulin
/ Manufacturers representatives
/ Quality of life
2021
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
New closed-loop insulin systems
by
Hovorka, Roman
, Boughton, Charlotte K
in
Closed loop systems
/ Diabetes
/ Diabetes mellitus (insulin dependent)
/ Insulin
/ Manufacturers representatives
/ Quality of life
2021
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
New closed-loop insulin systems
2021
Request Book From Autostore
and Choose the Collection Method
Overview
Advances in diabetes technologies have enabled the development of automated closed-loop insulin delivery systems. Several hybrid closed-loop systems have been commercialised, reflecting rapid transition of this evolving technology from research into clinical practice, where it is gradually transforming the management of type 1 diabetes in children and adults. In this review we consider the supporting evidence in terms of glucose control and quality of life for presently available closed-loop systems and those in development, including dual-hormone closed-loop systems. We also comment on alternative ‘do-it-yourself’ closed-loop systems. We remark on issues associated with clinical adoption of these approaches, including training provision, and consider limitations of presently available closed-loop systems and areas for future enhancements to further improve outcomes and reduce the burden of diabetes management.
Publisher
Springer Nature B.V
This website uses cookies to ensure you get the best experience on our website.